The dose—Response relationship of controlled-release codeine (Codeine Contin) in chronic cancer pain
- 31 August 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 9 (6) , 363-371
- https://doi.org/10.1016/0885-3924(94)90173-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A clinical study on the use of codeine, oxycodone, dextropropoxyphene, buprenorphine, and pentazocine in cancer painJournal of Pain and Symptom Management, 1991
- Controlled release morphine tablets: a double‐blind trial in patients with advanced cancerAnaesthesia, 1987
- Management of Cancer Pain With Oral Controlled‐Release Morphine SulfateThe Journal of Clinical Pharmacology, 1987
- Dosage Range Study of Morphine Sulfate Controlled-ReleaseAmerican Journal of Clinical Oncology, 1986
- Analysis of the Analgesic Efficacy of Acetaminophen 1000 mg, Codeine Phosphate 60 mg, and the Combination of Acetaminophen 1000 mg and Codeine Phosphate 60 mg in the Relief of Postoperative PainPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1986
- A Double‐Blind Comparison of Orally Administered Ciramadol and Codeine for Relief of Postoperative PainThe Journal of Clinical Pharmacology, 1985
- Combination AnalgesicsThe American Journal of Medicine, 1984
- An Appraisal of Codeine as an Analgesic: Single‐Dose AnalysisThe Journal of Clinical Pharmacology, 1984
- Oral Morphine for Relief of Chronic Pain from CancerNew England Journal of Medicine, 1981
- Relief of Pain with Oral MedicationsAustralian and New Zealand Journal of Medicine, 1976